ClassID:

20634

A61K35/413 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Digestive system Gall bladder; Bile

Recent Application in this class:
#1
20260144804
2026-05-28

USE OF HYOCHOLIC ACID (HCA) SPECIES IN PREPARATION OF MEDICAMENT FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA

#2
20260022346
2026-01-22

HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME

#3
20250367139
2025-12-04

COMPOUND HYDROCORTISONE AND NEOMYCIN SULFATE GRANULE AND PREPARATION METHOD THEREOF

#4
20250302900
2025-10-02

Method of Treating Heart Failure and Traditional Chinese Medicine Composition for Treating Heart Failure

#5
20250017978
2025-01-16

TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF

#6
20240261400
2024-08-08

METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB

#7
20240122991
2024-04-18

Transplantation of Liver Cells by Administration to the Biliary Tree of the Liver

#8
20240050504
2024-02-15

Traditional chinese medicine eye drops and the preparation method thereof

#9
20230357725
2023-11-09

LIVER MICROTISSUE AND USES IN TREATMENT OF LIVER FAILURE

#10
20230080878
2023-03-16

APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION

#11
20220362107
2022-11-17

METHOD FOR PREPARING ANTI-HEPATOMA DRUG SANJIE TABLET

#12
20220233605
2022-07-28

METHODS OF MAKING AND USING LIVER CELLS

#13
20220054495
2022-02-24

Compositions and methods for enhanced delivery of antiviral agents

#14
20220008495
2022-01-13

APPLICATION OF PHLEGMYHEATCLEAR IN PREPARATION OF DRUG FOR TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#15
20210330683
2021-10-28

COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS

#16
20210180026
2021-06-17

HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME

#17
20210139856
2021-05-13

Methods of expanding cholangiocytes

#18
20210100900
2021-04-08

Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

#19
20210015874
2021-01-21

USE OF BIO-TRANSFORMED BEAR BILE POWDER IN PREPARATION OF ANTI-INFLAMMATORY DRUGS

#20
20200316207
2020-10-08

POLYMERIC BILE ACID NANOPARTICLES AS ANTI-INFLAMMATORY AGENTS

#21
20200315982
2020-10-08

POLYMERIC BILE ACID ESTER NANOPARTICLES TO INDUCE TOLERANCE

#22
20190194608
2019-06-27

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#23
20180187160
2018-07-05

In vitro production of cholangiocytes

#24
20170049886
2017-02-23

Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

#25
20160237400
2016-08-18

ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF

#26
20160235745
2016-08-18

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

#27
20150017253
2015-01-15

Composition for preventing or treating immune-related disease and oxidative-stress-related disease

#28
20140369995
2014-12-18

Combination therapy for treatment of patients with neurological disorders and cerebral infarction

#29
20130190281
2013-07-25

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

#30
20130116218
2013-05-09

Methods and compositions of bile acids

#31
20110250183
2011-10-13

Combination therapy for treatment of patients with neurological disorders and cerebral infarction

#32
20110135610
2011-06-09

Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same

#33
20110111047
2011-05-12

Combination preparation of a biological response modifier and an anticancer agent and uses thereof

#34
20100130426
2010-05-27

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

#35
20090233888
2009-09-17

TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH

#36
20090111736
2009-04-30

Orally-Absorbed Solid Dose Formulation for Vancomycin

#37
20090010913
2009-01-08

Natural liniment for treatment of skin cancers

#38
20080279957
2008-11-13

Immunomodulating compositions from bile

#39
20080279818
2008-11-13

Combination Preparation of a Biological Response Modifier and an Anticancer Agent and Uses Thereof

#40
20070264352
2007-11-15

Biostimulate and tonic solution for massage (solution "Biplatvirs")

#41
20070129316
2007-06-07

Muscle-strengthening drugs and anti-inflammatory drugs

#42
20070041993
2007-02-22

Compositions and methods for symptomatic relief

#43
20060089331
2006-04-27

Methods and compositions for reducing toxicity of a pharmaceutical compound

#44
20060051319
2006-03-09

Neuroprotective effect of solubilized UDCA in focal ischemic model

#45
20060034938
2006-02-16

Combination preparation of a biological response modifier and an anticancer agent and uses thereof

#46
20050208653
2005-09-22

Method of isolating bile duct progenitor cells

#47
20050192443
2005-09-01

Biological response modifier for the treatment of cancer

#48
20050129780
2005-06-16

Relief of aids symptoms